| 2025-10-25 |
DSVFBOM8143750 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6914.0 kg |
170260.0
|
CONT. X ??REEFER CONTAINER SLAC? ?? ?? PACKAGES IN PALLETS????GLY.&MET.H CL . / MG TABS S,US??HSN CODE: ??BATCH NO : ??MFG DATE:AUG- EXP.D ATE:JAN- ??INVOICE NO : DT: . . ??NET WGT: . KGS??GROSS WGT: . KGS??????GLY.&MET.HCL . / MG TABS S,U S??HSN CODE: ?? |
| 2025-09-29 |
DSVFBOM8143061 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5812.0 kg |
310510.0
|
NARATRIPTAN TABLETS |
| 2025-09-22 |
DSVFBOM8141964 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3007.0 kg |
170260.0
|
DOXYCYCLINE TABLETS MG , S US??HSN CODE: ??BATCH NO: MFG DATE:JUL- EXP DATE:JUN- ??INVOICE NO : DT: . . ??NET WGT: . KGS ??GROSS WGT: . KGS????DOXYCYCLINE TABLETS MG , S US??HSN CODE: ??BATCH NO: MFG DATE:JUL- EXP DATE:JUN- ??INV OICE NO : DT: . . ??NET W |
| 2025-09-02 |
NXGWHYDDCP22184 |
RISING PHARMA HOLDINGS INC |
1091.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-08-15 |
DSVFBOM8139900 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6318.0 kg |
300490
|
1 CONT. 40 X9 6 ??REEFER CONTAINER SLAC? ?? ?? 2939 PACKAGES IN 19 PALLETS????GLYB.& MET . HCL 5/500MG TABS,100 S,US??HSN CODE:30049099??BATCH NO :18039102 MFG DATE:MAY-2025 EXP DATE:APR-2027??INVOICE NO : 1107005787 DT:30.06.2025??NET WGT:1970.336 KGS??G |
| 2025-08-15 |
DSVFBOM8139829 |
WILSHIRE PHARMACEUTICALS INC |
2029.0 kg |
310510
|
PERPHENAZINE TABLETS |
| 2025-08-08 |
DSVFBOM8139736 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6317.0 kg |
300420
|
1 CONT. 40 X9 6 ??REEFER CONTAINER SLAC? ?? ?? 2238 PACKAGES IN 20 PALLETS????DOXYCYCLIN E HYCLATE DR TAB150MG,100 S US??HSN CODE:300420 49??BATCH NO :18039048??MFG DATE:MAY-2025 EXP.DATE:APR-2028??INVOICE NO :1107005753 DT :25.06.2025??NET WGT:280.060 KG |
| 2025-08-08 |
DSVFBOM8139895 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3484.0 kg |
300420
|
1 CONT. 40 X9 6 ??REEFER CONTAINER SLAC? ?? ??911 PACKAGES IN 18 PALLETS????DOXYCYCLINE TABLETS 75MG , 100 S US??HS CODE:30042049??BATCH NO :18039112 ??MFG DATE: MAY-2025 EXP DATE:APR-2028??INVOICE NO :1107005765 DT:26.06.2025??NET WGT:92.88 KGS??GROSS WG |
| 2025-08-01 |
MVLEV10018267 |
AVET PHARMACEUTICAL INC |
728.0 kg |
300490
|
04 PACKAGES (FOUR PACKAGES ONLY) PHARMACEUTICAL PRODUCTS IN TABLET FORMAT H.S.CODE 300490 SB NO 9500597 DT 29-MAR-2025 TEMP. +20 DE GREE CELSIUS |
| 2025-07-19 |
DSVFBOM8137929 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4657.0 kg |
310510
|
DOXYCYCLINE TABLETS |
| 2025-07-09 |
NXGWHYDDAL58026 |
RISING PHARMA HOLDINGS INC |
1751.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-06-17 |
DSVFBOM8136875 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3069.0 kg |
300490
|
1 CONT. 40 X9 6 ??REEFER CONTAINER SLAC? ?? 1952 PACKAGES IN 14 PALLETS??FELODIPINE E R TABLETS 2.5 MG 100 S??HSN CODE:30049079??BATCH NO :18038918 MFG DATE:APR-2025 EXP DATE:MAR-2027??INVOICE NO :1107005607 DATED : 30.04.2025??NET WGT224.400 KGS??GROSS WGT :349.02 0 KGS??SB.NO :1438027 DT 01-MAY-2025????DOXY CYCLINE TABLETS 100MG , 50 S US??BATCH NO :18038927 MFG DATE:APR-2025 EXP DATE:MAR-2028??HSN CODE:30042049??FELODIPINE ER TABLETS 2.5 MG 100 S??HSN CODE:30049079??BATCH NO :18038903 MFG DATE:MAR-2025 EXP DATE:FEB-2027??INVOI CE NO :1107005607 DATED : 30.04.2025??NET WGT:741.400 KGS??GROSS WGT :1085.139 KGS??SB.N O :1438032 DT 01-MAY-2025????DOXYCYCLINE TABL ETS 50MG , 100 S US??HSN CODE:30042049??BATCHNO : MFG DATE:APR-2025 EXP DATE:MAR-2028??FE LODIPINE ER TABLETS 2.5 MG 100 S??HSN CODE:3004 90 79??BATCH NO :18038904 MFG DATE:MAR-2025 EXP DATE:FEB-2027??INVOICE NO : 1107005609 DT:30.04.2025??NET WGT:614.540 KGS??GROSS W GT :904.988 KGS??SB.NO :1438024 DT 01-MAY-20 25???? |
| 2025-06-17 |
DSVFBOM8136882 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3107.0 kg |
300420
|
1 CONT. 40 X9 6 ??REEFER CONTAINER SLAC? ? ??? 1502 PACKAGES IN 15 PALLETS????DOXYCYCLI NE TABLETS 100MG ,50 S US??HSN CODE:30042049??BATCH NO :18038928 MFG DATE:APR-2025 EXP DATE:MAR-2028??INVOICE NO :1107005611 DATED : 30.04.2025??NET WGT:1012.820 KGS??GROSS WGT :1 447.186 KGS??SB.NO :1436013 DT 01-MAY-2025??? ?DOXYCYCLINE TABLETS 100MG , 500 S US??HSN CODE:3004 20 49??BATCH NO :18038926 MFG DATE:APR-2025 EXP DATE:MAR-2028??INVOICE NO :1107005612 DATED : 30.04.2025??NET WGT:524.250 KGS? ?GROSS WGT :644.130 KGS??SB.NO :1436013 DT 01-MAY-2025??????NARATRIPTAN TABLETS USP 1MG, 9 S US??HSN CODE:3004 90 99??BATCH NO :1803892 0 MFG DATE:APR-2025 EXP DATE:MAR-2028??INVOIC E NO :1107005613 DATED : 30.04.2025??NET WGT:272.373 KGS??GROSS WGT :500.559 KGS??SB.NO : 1436006 DT 01-MAY-2025????NARATRIPTAN TABLETSUSP 2.5 MG, 9 S US??HSN CODE:3004 90 99??BAT CH NO :18038921 MFG DATE:APR-2025 EXP DATE:MAR-2028??INVOICE NO :1107005614 DATED : 30.04.2025??NET WGT:302.882 KGS??GROSS WGT :515.54 0 KGS??SB.NO :1435943 DT 01-MAY-2025????????T EMP SETTING 20C??SCAC CODE:DSVF??CONISGNEE ID:BOM8136882 |
| 2025-05-14 |
NXGWHYDCYV24193 |
RISING PHARMA HOLDINGS INC |
359.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-05-07 |
DSVFBOM8134460 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5551.0 kg |
293629
|
CONSIGNOR:?? USV PRIVATE LTD, ??ARVIND VITHALGANDHI CHOWK NULL NULL ??B.S.D MARG, GOVANDI ??MU MBAI 400 088, INDIA ??CONSIGNEE: AVET PHARMACEUTICAL INC??5650 CHALLENGE DRIVE, MEMPHIS, TN 38118 USA |
| 2025-05-07 |
DSVFBOM8134458 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5217.0 kg |
293629
|
CONSIGNOR:?? USV PRIVATE LTD, ??ARVIND VITHALGANDHI CHOWK NULL NULL ??B.S.D MARG, GOVANDI ??MU MBAI 400 088, INDIA ??CONSIGNEE: AVET PHARMACEUTICAL INC??5650 CHALLENGE DRIVE, MEMPHIS, TN 38118 USA ???? |
| 2025-04-15 |
KWEO530440074653 |
SOLA PHARMACEUTICALS |
886.0 kg |
190120
|
OLOPATADINE HCL OPH. SOL.USP0.1% SOLA US |
| 2025-04-11 |
DSVFBOM8133388 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6028.0 kg |
310510
|
GLYBURIDE TABLETS |
| 2025-03-18 |
NXGWHYDCWY58043 |
RISING PHARMA HOLDINGS INC |
2933.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-03-15 |
DSVFBOM8131975 |
AVET PHARMACEUTICALS INC |
4337.0 kg |
960831
|
CONSIGNOR: USV PRIVATE LTD, ARVIND VITHAL GANDHI CHOWK NULL NULL B.S.D MARG, GOVANDI MU MBAI 400 088, INDIA CONSIGNEE: AVET PHARMAC EUTICAL INC 5650 CHALLENGE DRIVE, MEMPHIS, TN 38118 USA |
| 2025-03-15 |
DSVFBOM8131820 |
AVET PHARMACEUTICALS INC |
6215.0 kg |
|
METFORMINHCL500MGTAB |
| 2025-02-07 |
DSVFBOM8129731 |
HERITAGE PHARMA LABS INC |
3786.0 kg |
300420
|
1 CONT. 40 X9 6 REEFER CONTAINER SLAC 769 PACKAGES IN 23 PALLETSDOXYCYCLINE TABLETS 1 00MG , 500 S USHSN CODE:30042049BATCH NO :18038361MFG DATE:NOV-2024 EXP DATE:OCT-2027INVOICE NO :1107005153 DT:20.12.2024NET WGT:531.240 KGSGROSS WGT:652.644 KGSGLIPIZIDE 2.5MG & METFORMIN HCL250 MG 100HSN CODE:30049099BATCH NO :18038273MFG DATE:OCT-2024 EXP DATE:MAR-2 026INVOICE NO :1107005154 DT:20.12.2024NET WGT:158.400 KGSGROSS WGT:214.680 KGSNARATRIPTA N TABLETS USP 2.5 MG, |
| 2025-01-31 |
PUSJS2400813132 |
R&S SOLUTIONS LLC |
1302.0 kg |
830990
|
ACETAZOLAMIDE ER CAPSULES 500MG 100 S |
| 2025-01-11 |
DSVFBOM8128507 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5819.0 kg |
|
PHARMA |
| 2024-12-15 |
DSVFBOM8127386 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3453.0 kg |
300420
|
1 CONT. 40 X9 6 REEFER CONTAINER SLAC 1334 PACKAGES IN 13 PALLETSDOXYCYCLINE TABLETS 15 0MG , 30 S USHSN CODE:30042049BATCH NO:18038129 MFG DATE:SEP-2024 EXP DATE:AUG-2027INVOICENO : 1107004999 DT:28.10.2024NET WGT:170.520 KGS GROSS WGT:246.960 KGSSB.NO :5204571 D T 28-OCT-2024GLIPIZIDE 5MG & METFORMIN HCL 50 0MG TAB 100SHSN CODE:30049099BATCH NO:18038091 MFG DATE:SEP-2024 EXP DATE:FEB-2026INVOICE NO : 1107005000 DT:28.10.2024NET WGT:627.640 KGS GROSS WGT:800.14 |
| 2024-11-17 |
DSVFBOM8125366 |
HERITAGE PHARMACEUTICALS DBA AVET P |
2904.0 kg |
300490
|
1 CONT. 40 X9 6 REEFER CONTAINER SLAC 756 PACKAGES IN 14 PALLETSFELODIPINE ER TABLETS 10 MG 100 SHSN CODE:30049079BATCH NO:18038022 MFG DATE:AUG-2024 EXP DATE:JUL-2026INVOICE NO:1107004907 DT:27.09.2024NET WGT:571.582 KGS GROSSW GT:767.854 KGSSB.NO :4420179 DT 28-SEP-2024FELODIPINE ER TABLETS 10 MG 100 SHSN COD E:30049079BATCH NO:18038021 MFG DATE:AUG-2024EXP DATE:JUL-2026INVOICE NO :1107004906 DT:2 7.09.2024NET WGT:573.500 KGSGROSS WGT: 769.772 KGSSB.NO :4420180 DT 28- |
| 2024-11-16 |
NXGWHYDCSB22752 |
RISING PHARMA HOLDINGS INC |
4020.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-10-08 |
DSVFBOM8123577 |
HERITAGE PHARMACEUTICALS DBA AVET P |
8319.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-09-10 |
NXGWHYDCNZ91585 |
RISING PHARMA HOLDINGS INC |
4322.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-08-29 |
DSVFBOM8121807 |
HERITAGE PHARMACEUTICALS DBA AVET P |
2255.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-08-29 |
DSVFBOM8120402 |
HERITAGE PHARMACEUTICALS DBA AVET P |
2902.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-08-27 |
DSVFBOM8120753 |
HERITAGE PHARMACEUTICALS DBA AVET P |
7496.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-07-30 |
FJLAJF02SEH29921 |
SST CORP |
13770.0 kg |
291229
|
METFORMIN HYDROCHLORIDE USP 100 |
| 2024-07-30 |
CUIACTLMU2403165 |
SST CORP |
2804.0 kg |
291229
|
MET. HYDROCHLORIDE USP . |
| 2024-07-27 |
NXGWHYDCMF72046 |
RISING PHARMA HOLDINGS INC |
1899.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-07-10 |
DSVFBOM8119140 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6375.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-07-08 |
NXGWHYDCLP43933 |
RISING PHARMA HOLDINGS INC |
993.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-06-02 |
NEDFHYDCKX35274 |
RISING PHARMA HOLDINGS INC |
1184.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-05-18 |
NEDFHYDCKD32890 |
RISING PHARMA HOLDINGS INC |
2718.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-04-23 |
NEDFHYDCJT11986 |
RISING PHARMA HOLDINGS INC |
1728.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-04-01 |
DSVFBOM8114247 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4817.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-03-13 |
NEDFHYDCHL55855 |
RISING PHARMA HOLDINGS INC |
1204.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-03-02 |
DSVFBOM8112231 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4522.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-02-27 |
NEDFHYDCGL95290 |
RISING PHARMA HOLDINGS INC |
2688.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-02-01 |
DSVFBOM8110891 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3428.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-01-22 |
NEDFHYDCFV85605 |
RISING PHARMA HOLDINGS INC |
916.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2024-01-21 |
DSVFBOM8109555 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4357.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2024-01-21 |
DSVFBOM8109419 |
AVET PHARMACEUTICALS INC |
4902.0 kg |
310510
|
FILODIPINE ER TABLETS |
| 2023-12-14 |
DSVFBOM8108163 |
AVET PHARMACEUTICALS INC |
4166.0 kg |
310510
|
FELODIPINE ER TABLETS |
| 2023-11-18 |
NEDFHYDCDZ76645 |
RISING PHARMA HOLDINGS INC |
557.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |